Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Condensed Balance Sheets (Parenthetical)

v3.25.1
Consolidated Condensed Balance Sheets (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Accounts Receivable, Allowance $ 45 $ 151
Stockholders' equity:    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 300,000 300,000
Common stock, shares issued (in shares) 30,960 18,154
Common stock shares outstanding (in shares) 30,663 17,855